---

1.媒體來源:
CBS NEWS(美國哥倫比亞廣播公司:CBS晚間新聞開始播出於1950年，是美國最早
的晚間新聞節目，在美國電視新聞界擁有重要地位。)

2.記者署名:
NATACHA LARNAUD

3.完整新聞標題:
Researchers look into cannabis as a potential COVID-19 treatment

4.完整新聞內文:
As new daily coronavirus infections continue to break records in the U.S.,
researchers are considering whether the cannabis plant has the potential to
be used in the treatment of COVID-19.

Institute are recommending that scientists study the anti-inflammatory
properties in CBD as a potential treatment for lung inflammation caused by
the coronavirus.
內布拉斯加州大學和德州生物醫學研究所的專家建議，研究CBD中
的抗發炎特性作為治療冠狀病毒引起的肺部炎症的潛在方法。

There is no scientific evidence that cannabis or its compounds can help with
COVID-19 specifically, but in a peer-reviewed article in Brain, Behavior, and
Immunity, the authors said further research is needed to understand if CBD
can help patients infected by the virus.


Emily Earlenbaugh, a Forbes contributor and co-founder of Mindful Cannabis
Consulting, joined CBSN to discuss the study. She explained that in severe
cases of COVID-19, the body's immune system overreacts and releases too many
cytokines, which is called a "cytokine storm."

"Cytokines will normally help to create inflammation to fight off
infections," Earlenbaugh said. "But in these extreme cases, you see so much
cytokines being released into the system that it creates a cytokine storm.
You might see high fever, inflammation, severe fatigue and nausea, and in
serious cases, it can lead to death through organ failure."

Earlenbaugh said CBD is known from previous research as an IL-6 cytokine
inhibitor, meaning it helps reduce the production of cytokines.
富比世雜誌作家、Mindful Cannabis Consulting共同創辦人Emily Earlenbaugh


但在先前的研究指出CBD被稱為IL-6細胞因子抑製劑，這意味著它有助於
減少細胞因子的產生。

The authors of the study wrote that one drug, Tocilizumab, resulted in the
"clearance of lung consolidation and recovery" in 90% of the 21 treated
patients. The drug, however, resulted in adverse side effects like pancreas
inflammation and hypertriglyceridemia.

Researchers then turned to cannabis, specifically CBD. The authors said that
several cannabinoids in the cannabis plant have anti-inflammatory properties.
They said CBD "has shown beneficial anti-inflammatory effects in pre-clinical
models of various chronic inflammatory diseases" and noted that the FDA
approved one CBD product to treat certain forms of epilepsy.


"CBD has very few side effects, so it's something that's being looked at as a
much more mild treatment that still has a lot of anti-inflammatory powers,"
Earlenbaugh told CBSN.
Earlenbaugh告訴CBSN：“ CBD幾乎沒有副作用，因此它是一種更溫和的治
療方法，且具有非常強大的消炎作用。”

The authors of the study said that CBD can help reduce anxiety in patients
and increase the production of interferons, a protein that helps the body
fight infections.

But given the early stages of this research, Earlenbaugh said she would
"definitely express caution" against using cannabis as a treatment for
COVID-19. She said some researchers have warned using the drug early on in
the infection stages could cause negative side effects.
但有鑑於目前還在研究早期，不建議使用大麻作為治療手段。

"We're pretty far away from human research that could really definitively
answer those questions for us," Earlenbaugh said. "The other reason for
caution is that cytokines are important in fighting off infections. So, we
don't want to reduce them as a preventative measure or in early stages of the
infection."
5.完整新聞連結 (或短網址):
https://risu.io/9O0J

6.備註:
醫用大麻幾乎不會爽 製劑更不會

大麻在台灣還是超級違法

--
--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 180.176.10.168 (臺灣)
※ 文章代碼(AID): #1V67Qnnn (Gossiping)
※ 文章網址: https://www.ptt.cc/bbs/Gossiping/M.1595438769.A.C71.html